SCHEMBL4670263

SCHEMBL4670263

CCOC(=O)C1=C(C)N=c2sc(=Cc3ccc(OC)c(OC)c3)c(=O)n2C1c1ccccc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.84
NPSR1 Q6W5P4 2/20 0.84
MEN1 O00255 9/20 0.78
KMT2A Q03164 9/20 0.78
PSMD14 O00487 1/20 0.76
DNMT1 P26358 1/20 0.76
PTPN22 Q9Y2R2 2/20 0.71
TNF P01375 1/20 0.68
IL6 P05231 1/20 0.68
PTPN7 P35236 1/20 0.67
DUSP3 P51452 1/20 0.67
DUSP6 Q16828 1/20 0.67
CSNK2A2 P19784 2/20 0.66
CSNK2B P67870 2/20 0.66
CSNK2A1 P68400 2/20 0.66
CTDSP1 Q9GZU7 2/20 0.65
HTT P42858 1/20 0.64
USP2 O75604 1/20 0.63
POLB P06746 1/20 0.63
MAPT P10636 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4670262 1.00 ALDH1A1 (0.84) ALDH1A1NPSR1MEN1KMT2APSMD14
SCHEMBL13855965 0.92 ALDH1A1 (0.76) ALDH1A1NPSR1MEN1KMT2APSMD14
SCHEMBL12325907 0.90 ALDH1A1 (0.74) ALDH1A1NPSR1MEN1KMT2APSMD14
SCHEMBL14104258 0.89 ALDH1A1 (0.73) ALDH1A1NPSR1MEN1KMT2APSMD14
SCHEMBL14922115 0.88 ALDH1A1 (0.72) ALDH1A1NPSR1MEN1KMT2APSMD14
SCHEMBL4668189 0.88 MEN1 (0.82) ALDH1A1NPSR1MEN1KMT2ADNMT1
SCHEMBL4668190 0.88 MEN1 (0.82) ALDH1A1NPSR1MEN1KMT2ADNMT1
SCHEMBL13855930 0.88 MEN1 (0.71) ALDH1A1NPSR1MEN1KMT2APSMD14
SCHEMBL13855947 0.88 ALDH1A1 (0.87) ALDH1A1NPSR1MEN1KMT2APSMD14
SCHEMBL4669050 0.88 ALDH1A1 (0.78) ALDH1A1NPSR1MEN1KMT2APSMD14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2000140-A1 Use of derivatives of 3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine or of 3-oxo-2,3-dihydro-5H-imidazolo[3,2-a]pyrimidine for the preparation of pharmaceutical compositions intended for the treatment of cancer INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2008-12-10 EP disclosed